Shibutani Shusaku, Okazaki Hana, Iwata Hiroyuki
From the Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan
From the Laboratory of Veterinary Hygiene, Joint Faculty of Veterinary Medicine, Yamaguchi University, 1677-1 Yoshida, Yamaguchi 753-8515, Japan.
J Biol Chem. 2017 Nov 3;292(44):18052-18061. doi: 10.1074/jbc.M117.776443. Epub 2017 Aug 14.
The mechanistic target of rapamycin complex 1 (mTORC1) is a master regulator of protein synthesis and potential target for modifying cellular metabolism in various conditions, including cancer and aging. mTORC1 activity is tightly regulated by the availability of extracellular amino acids, and previous studies have revealed that amino acids in the extracellular fluid are transported to the lysosomal lumen. There, amino acids induce recruitment of cytoplasmic mTORC1 to the lysosome by the Rag GTPases, followed by mTORC1 activation by the small GTPase Ras homolog enriched in brain (Rheb). However, how the extracellular amino acids reach the lysosomal lumen and activate mTORC1 remains unclear. Here, we show that amino acid uptake by dynamin-dependent endocytosis plays a critical role in mTORC1 activation. We found that mTORC1 is inactivated when endocytosis is inhibited by overexpression of a dominant-negative form of dynamin 2 or by pharmacological inhibition of dynamin or clathrin. Consistently, the recruitment of mTORC1 to the lysosome was suppressed by the dynamin inhibition. The activity and lysosomal recruitment of mTORC1 were rescued by increasing intracellular amino acids via cycloheximide exposure or by Rag overexpression, indicating that amino acid deprivation is the main cause of mTORC1 inactivation via the dynamin inhibition. We further show that endocytosis inhibition does not induce autophagy even though mTORC1 inactivation is known to strongly induce autophagy. These findings open new perspectives for the use of endocytosis inhibitors as potential agents that can effectively inhibit nutrient utilization and shut down the upstream signals that activate mTORC1.
雷帕霉素靶蛋白复合物1(mTORC1)是蛋白质合成的主要调节因子,也是在包括癌症和衰老在内的各种情况下改变细胞代谢的潜在靶点。mTORC1的活性受到细胞外氨基酸可用性的严格调控,先前的研究表明细胞外液中的氨基酸会被转运到溶酶体腔中。在那里,氨基酸通过Rag GTP酶诱导细胞质中的mTORC1募集到溶酶体,随后由富含脑的小GTP酶Rheb激活mTORC1。然而,细胞外氨基酸如何到达溶酶体腔并激活mTORC1仍不清楚。在此,我们表明依赖发动蛋白的内吞作用摄取氨基酸在mTORC1激活中起关键作用。我们发现,当通过过表达显性负性形式的发动蛋白2或通过药理学抑制发动蛋白或网格蛋白来抑制内吞作用时,mTORC1会失活。一致地,发动蛋白抑制会抑制mTORC1向溶酶体的募集。通过环己酰亚胺处理增加细胞内氨基酸或通过Rag过表达可挽救mTORC1的活性和向溶酶体的募集,这表明氨基酸剥夺是通过发动蛋白抑制导致mTORC1失活的主要原因。我们进一步表明,即使已知mTORC1失活会强烈诱导自噬,但内吞作用抑制并不会诱导自噬。这些发现为使用内吞作用抑制剂作为能够有效抑制营养物质利用并阻断激活mTORC1的上游信号的潜在药物开辟了新的前景。